Caplacizumab is a von Willebrand factor (vWF)-directed antibody fragment designed to inhibit the interaction between vWF and platelets.

What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and ...

The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...

The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...

Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP ...

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).

Texas Children's Hospital in Austin performs fetal blood transfusion to save the life of baby exposed to childhood illness.

The American Red Cross urges donors to make an appointment to give blood or platelets now to keep the blood supply as strong ...

The American Red Cross urges donors to make an appointment to give blood or platelets now to keep the blood supply as strong ...

The American Red Cross urges donors to make an appointment to give blood or platelets now to keep the blood supply as strong ...

The approval was based on data from the single-arm, open-label phase 2 KOMET-001 trial, which evaluated ziftomenib, a menin inhibitor, in adults with R/R AML with an NPM1 mutation.

In a new statement, the American Heart Association outlines growing evidence linking gum disease to a higher risk for ...